Literature DB >> 17936091

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.

Judith Korner1, Marc Bessler, William Inabnet, Carmen Taveras, Jens Juul Holst.   

Abstract

BACKGROUND: The aim of this study was to measure the circulating levels of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon in patients who had undergone adjustable gastric banding (BND) or Roux-en-Y gastric bypass (RYGB) to understand the differences in glucose and insulin regulation after these procedures.
METHODS: This was a cross-sectional study of 3 groups of women matched for age and body mass index: group 1, overweight controls (n = 13); group 2, BND (n = 10); and group 3, RYGB (n = 13). Venous blood was drawn with the patient in the fasted state and throughout a 3-hour period after a liquid meal.
RESULTS: The fasting glucose level was similar between the 2 surgery groups; however, the fasting insulin concentrations were greater in the BND (10.0 microU/mL) than in the RYGB (6.2 microU/mL; P <0.05) group. The glucose level at 60 minutes was significantly lower in the RYGB group (70 mg/dL, range 38-82) than in the BND group (83 mg/dL, range 63-98). The GLP-1 levels at 30 minutes were more than threefold greater in the RYGB group (96 pmol/L) compared with the BND and overweight control (28 pmol/L) groups. The GLP-1 and insulin concentrations correlated at 30 minutes only in the RYGB group (r = .66; P = .013). The glucose-dependent insulinotropic peptide levels at 30 minutes were lower in the RYGB group (20 pmol/L) than in the BND group (31 pmol/L) or overweight control group (33 pmol/L). The peak glucagon levels were similar among the 3 groups.
CONCLUSION: Exaggerated postprandial GLP-1 and blunted glucose-dependent insulinotropic peptide secretion after RYGB might contribute to the greater weight loss and improved glucose homeostasis compared with BND.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936091      PMCID: PMC2134840          DOI: 10.1016/j.soard.2007.08.004

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  23 in total

Review 1.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 2.  Minireview: the glucagon-like peptides.

Authors:  D J Drucker
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

3.  Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

Authors:  J J Holst; T I Sørensen; A N Andersen; F Stadil; B Andersen; K B Lauritsen; H C Klein
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

4.  Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.

Authors:  T Krarup; S Madsbad; A J Moody; L Regeur; O K Faber; J J Holst; L Sestoft
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

5.  Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.

Authors:  J J Holst
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

Review 6.  Incretins and other peptides in the treatment of diabetes.

Authors:  J F Todd; S R Bloom
Journal:  Diabet Med       Date:  2007-03       Impact factor: 4.359

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 8.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

9.  Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.

Authors:  J Miholic; C Orskov; J J Holst; J Kotzerke; H J Meyer
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

10.  The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats.

Authors:  H S Koopmans; G L Ferri; D L Sarson; J M Polak; S R Bloom
Journal:  Physiol Behav       Date:  1984-10
View more
  147 in total

1.  Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus.

Authors:  Woohyung Lee; Sang Hoon Ahn; Jue Hee Lee; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

Review 2.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Authors:  C Dirksen; N B Jørgensen; K N Bojsen-Møller; S H Jacobsen; D L Hansen; D Worm; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

Review 3.  Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Authors:  Konstantinos Michalakis; Carel le Roux
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

4.  Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

Authors:  Fabiola Romero; Joana Nicolau; Lílliam Flores; Roser Casamitjana; Ainitze Ibarzabal; Antonio Lacy; Josep Vidal
Journal:  Surg Endosc       Date:  2012-08       Impact factor: 4.584

5.  BMI guidelines for bariatric surgery in diabetes: how low can we go?

Authors:  Donna H Ryan
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

6.  Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery.

Authors:  Andrew C Shin; Huiyuan Zheng; R Leigh Townsend; David L Sigalet; Hans-Rudolf Berthoud
Journal:  Endocrinology       Date:  2010-02-23       Impact factor: 4.736

Review 7.  Mechanisms of weight loss and improved metabolism following bariatric surgery.

Authors:  Christopher M Mulla; Roeland J W Middelbeek; Mary-Elizabeth Patti
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

8.  Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Authors:  Matthew R Hayes; Elizabeth G Mietlicki-Baase; Scott E Kanoski; Bart C De Jonghe
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

9.  GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.

Authors:  Jianping Ye; Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Laurel M Patterson; Nicholas Stylopoulos; Heike Münzberg; Christopher D Morrison; Daniel J Drucker; Hans-Rudolf Berthoud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-15       Impact factor: 3.619

Review 10.  Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.

Authors:  Marzieh Salehi; David A D'Alessio
Journal:  Surg Obes Relat Dis       Date:  2016-05-11       Impact factor: 4.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.